Priya Rajakumar

Hematologist at @AdvocateAurora | Proud alumnus of @RushHemOnc | My tweets are my own and not medical advice.

[RUSH Heme/Onc @RushHemOnc]

Congrats to one of our own, @KMilladoMD for making the ASCO Daily News! Check out her commentary on the role of HIF-2a inhibition in advanced ccRCC! @alantanmd

[Priya Rajakumar @PRajakumarMD]

https://t.co/NUzkVN9afT

[Priya Rajakumar @PRajakumarMD]

While treatment paradigms for MM continue to evolve, some malignant PCs continue to evade even the most promising of new therapies. Here we demonstrate a case where precision medicine has successfully offered a therapeutic option in refractory NSMM. @RushHemOnc @ashiq_masood

[Mia Levy, MD, PhD @DrMiaLevy]

My coauthors and I researched a non-secretory multiple myeloma with an unusual TFG-ALK fusion that showed a dramatic response to ALK inhibition. Special thanks to those who contributed to this study. @nresearchnews https://t.co/ktpZk2gjJe

[Priya Rajakumar @PRajakumarMD]

Apparently if it’s not on the ‘gram (or in this case Twitter), it didn’t happen. Feeling very lucky to have received the COVID-19 vaccine today. Please get yours when it becomes available. #GetVaccinated #IGotTheShot

[RUSH Heme/Onc @RushHemOnc]

Global longitudinal strain and cardiac biomarkers (Troponin I and BNP) may predict those patients that are at higher risk of cardiotoxicty from cancer-directed therapy. Thank you @DrTochiOkwuosa for a very comprehensive and relevant Medicine Grand Rounds today! @RushIMChiefs

[Priya Rajakumar @PRajakumarMD]

@shivijain80 @RushCancer @RushUniversity Fantastic study and oral presentation! @RutaRaoMD

[Priya Rajakumar @PRajakumarMD]

Structural violence negatively impacts our patients every day. This study examines disease biology, SES, and treatment patterns in order to highlight racial/ethnic disparities in AML survival. Grateful to be included. Check out the oral abstract at #ASH20! @AmiADave @mlarsonmd

[Priya Rajakumar @PRajakumarMD]

Thankful for the opportunity to collaborate with @LoyolaOnc and @UIC_HO_Fellows on a retrospective review evaluating COVID-19 related thromboembolism in the Chicago Metropolitan area. Check out our oral abstract on replay in case you missed it! #ASH20 @RushCancer @sh_kimMD

[Priya Rajakumar @PRajakumarMD]

Kicking off our Saturday morning with amazing advice from one of the greats. #ASHFromHome #ASH20

[RUSH Heme/Onc @RushHemOnc]

Great advice on recommending vaccination for our immunocompromised patients despite them not being able to amount a great immune response. “Some degree of immunity is better than no degree.” Thank you Dr. Fauci for your leadership and inspiring all of us. @DrAnthonyF #ASH20

[RUSH Heme/Onc @RushHemOnc]

Say hello to Priya — our last chief fellow to introduce! Most people can recognize her by her laugh, but she is fierce on a bocce ball court! @PRajakumarMD @RushCancer @RushHemOnc

[RUSH Heme/Onc @RushHemOnc]

We are very excited to announce the Twitter account of the Hematology/Oncology fellowship program @RushCancer! We will be posting program highlights, events, tweetorials, and updates on our current and former fellows! @RushMedical #MedEd #Hematology #Oncology

[Priya Rajakumar @PRajakumarMD]

@katielwelter Very scrub friendly poses!! 🙌🏽

[Mia Levy, MD, PhD @DrMiaLevy]

First good news in a while, 3rd day in a row Illinois has new #COVID case count below the exponential growth curve!! #SocialDistancing may be working! Keep it up everyone.

[Priya Rajakumar @PRajakumarMD]

Great to have collaborated on a multi-institution, Chicago-based initiative to evaluate healthcare disparities in our AML population. Come check out the poster! @mlarsonmd @RushCancer

[Anand Patel @Anand_88_Patel]

Come check our poster to be presented by Dr Ivy Abraham tonight evaluating disparities in treatment patterns/outcomes in AML! Was great to have a collaboration betweeen @UICancerCenter @LurieCancer @RushMedical @UCCancerCenter @CookCtyHealth #ASH19 #leusm https://t.co/z5HiPqYLmc

[Priya Rajakumar @PRajakumarMD]

@TMSchmidtMD1 @WinshipAtEmory @kaufman_MMdoc Great accomplishment! Congratulations!

[Nina Shah @ninashah33]

“Mark” my words! T(11:14) and high Bcl2 are predictive biomarkers for response to ven-bortez-dex. PFS not reached yet! Time to move on from the Bellini drama and study ven specifically in this subgroup of pts. #mmsm #ASH19

[Priya Rajakumar @PRajakumarMD]

Rush representing at #ASH2019! @RushCancer

[NEJM @NEJM]

#VisualAbstract: Gilteritinib vs. Salvage Chemotherapy for AML https://t.co/NbEg5EIdKp

[Priya Rajakumar @PRajakumarMD]

Visual abstracts help effectively convey scientific information on social media. No more Kaplan Meier curves! Thank you @edgarvlermamd for a wonderful talk on incorporating social media into academic medicine. @RushDOIM @RushCancer

[Priya Rajakumar @PRajakumarMD]

❤️

[Michelle Obama @MichelleObama]

27 years ago, this guy promised me a life full of adventure. I’d say he’s delivered. Here’s to our next chapter of becoming empty nesters and discovering what’s next—while still feeling the magic that brought us together all those years ago. Happy anniversary, Barack.